|

Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Saint Vincent's Hospital, Korea1

Indications

  • Dyslipidemias1
  • Heart Disease1
  • Primary Prevention1
  • Coronary Artery Disease1

Other1 trial

Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.